SAN DIEGO, July 3, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, both dates inclusive (the "Class Period"), have until...
Read More Details
Finally We wish PressBee provided you with enough information of ( RCKT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit )
Also on site :
- Syria Launches New National Visual Identity
- Supreme Court clears way for deportation to South Sudan of several immigrants with no ties there
- Metal Fan Reveals She Owns 54 Different Versions of Classic Album Ahead of Band's Final Show